Butzel adds FDA/FTC/Government Relations attorney in its Washington, D.C. office


WASHINGTON, D.C. –  Attorney Mark Mansour has joined Butzel as a shareholder in the firm’s Washington, D.C. office. Over the years, he has built a practice focused on FDA/FTC/Government Relations. Moreover, he also practices domestic and international government relations.

He is highly experienced in securing Food and Drug Administration (FDA) approvals for medical devices, managing medical device safety issues, managing recalls, market access issues, food and nutrition issues, dietary supplement regulation, agribusiness, and the regulation of cannabis products at the state and federal level. He is known among his clients for his innovative approach to issues, responsiveness and practical business advice.

Mansour has extensive experience working with clients to resolve advertising issues involving the National Advertising Division (NAD) and the Federal Trade Commission (FTC). He has experience addressing social media regulation and has revised numerous corporate websites to ensure compliance with FTC requirements.

In addition, he has significant in-house experience as counsel with two major multinational companies. Mansour is well-known for his innovative, business focused approach to problem-solving as well as strong client relations skills.

He takes a holistic business-oriented approach to client issues. He works with both attorneys and business units to ensure that objectives are clearly identified and met. He also assists clients and colleagues with FDA issues involving litigation and due diligence for corporate mergers and acquisitions, and internal, civil and criminal investigations.

Mansour earned a J.D. from Georgetown University Law School; an M.A. from Harvard University; and, a B.S., cum laude, Phi Beta Kappa, from Georgetown University. He is a member of the Food and Drug Law Institute, American Bar Association (ABA) Regulatory Section and The DC Bar Regulatory Section.

What's Trending

Follow us on social media

Jump to Page

By using this site, you agree to our updated Privacy Policy and our Terms of Use.